DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes

BACKGROUND: Recent studies have shown the beneficial effect of dipeptidyl peptidase-4 (DPP4) inhibitor on bone turnover in diabetes mellitus. However, little clinical evidence for DPP4 activity in newly diagnosed type 2 diabetes is available. This study was designed to investigate the relationship b...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Min, Zhai, Shuheng, Liu, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719533/
https://www.ncbi.nlm.nih.gov/pubmed/33312197
http://dx.doi.org/10.1155/2020/8874272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719533/
https://www.ncbi.nlm.nih.gov/pubmed/33312197
http://dx.doi.org/10.1155/2020/8874272

Ejemplares similares